OTCMKTS:DIGP

DigiPath Stock Forecast, Price & News

$0.04

0.00 (0.00 %)

(As of 04/16/2021 12:00 AM ET)

Add

Compare

Today's Range

$0.04

Now: $0.04▼

$0.05

50-Day Range

$0.05

MA: $0.05▼

$0.06

52-Week Range

$0.01

Now: $0.04▼

$0.10

Volume186,086 shs

Average Volume233,049 shs

Market Capitalization$2.89 million

P/E RatioN/A

Dividend YieldN/A

Beta1.71

DigiPath, Inc., together with its subsidiaries, provides cannabis and hemp lab testing services in Las Vegas to Nevada licensed medical marijuana enterprises. It also provides testing, cannabis education and training, and unbiased cannabis news coverage to the cannabis industry. The company operates as a testing laboratory facility for cannabis, cannabis infused products, hemp, and other botanical nutraceuticals to serve growers, dispensaries, caregivers, producers, patients, and end users of cannabis and botanical products. DigiPath, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Management consulting services

Sub-IndustryCannabis

SectorMedical

Current SymbolOTCMKTS:DIGP

Previous Symbol

CUSIPN/A

CIK1502966

Webwww.digipath.com

Phone702-527-2060

Employees18

Year FoundedN/A

Debt

Debt-to-Equity RatioN/A

Current Ratio0.32

Quick Ratio0.30

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$2.55 million

Price / Sales1.13

Cash FlowN/A

Price / Cash FlowN/A

Book Value$0.01 per share

Price / Book4.24

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$-1,800,000.00

Net Margins-67.99%

Return on Equity-1,137.19%

Return on Assets-88.49%

Miscellaneous

Outstanding Shares68,182,000

Market Cap$2.89 million

Next Earnings Date5/17/2021 (Estimated)

OptionableNot Optionable

Headlines

DigiPath, Inc. (OTCMKTS:DIGP) Short Interest Update
April 13, 2021 | americanbankingnews.com

DigiPath, Inc. (OTCMKTS:DIGP) Short Interest Up 544.4% in March
March 27, 2021 | americanbankingnews.com

Cannabis Testing Market Insight, Aspects, Review, and Survey Reports 2025
September 4, 2020 | marketwatch.com

Digipath, Inc.: Digipath Announces Results for Third Fiscal Quarter 2020
August 25, 2020 | bloomberg.com

Digipath Announces Results for Third Fiscal Quarter 2020
August 17, 2020 | finance.yahoo.com

Digipath, Inc.: Digipath Announces Results for Second Fiscal Quarter 2020, Revenues Grow 16% and 21% on a Year to Date Basis
May 21, 2020 | www.bloomberg.com

Digipath Announces Results for Second Fiscal Quarter 2020, Revenues Grow 16% and 21% on a Year to Date Basis
May 18, 2020 | finance.yahoo.com

Digipath to Import & Export Cannabis Genetics via Health Canada R&D License
April 15, 2020 | finance.yahoo.com

Digipath Inc.
March 28, 2020 | www.marketwatch.com

Digipath Completes Acquisition of VSSL Enterprises Ltd.
March 16, 2020 | finance.yahoo.com

The Emerging Markets Report: A Record Rise in Revenue
February 20, 2020 | www.globenewswire.com

The Emerging Markets Report: A Record Rise in Revenue
February 20, 2020 | finance.yahoo.com

Digipath Announces Results for the Fiscal First Quarter 2020, Revenues Grow 26%
February 18, 2020 | finance.yahoo.com

Emerging Markets Report: At the Intersection of Cannabis and Commerce
February 5, 2020 | www.globenewswire.com

Emerging Markets Report: At the Intersection of Cannabis and Commerce
February 5, 2020 | finance.yahoo.com

Digipath Processes Record Number of Samples, Plans Expansion
February 4, 2020 | finance.yahoo.com

Digipath Inc
October 3, 2019 | markets.ft.com

GroSciences Initiates Beta-testing of Tru-Hemp ID In North Carolina and Vermont
August 28, 2019 | finance.yahoo.com

Digipath's GroSciences Moving Forward with Further Testing for its Patent Pending All-Natural, Plant-Derived Pesticide
August 14, 2019 | finance.yahoo.com

Digipath Reports Significant Progress on GroSciences' Tru-Hemp ID Kit
July 29, 2019 | finance.yahoo.com

See More Headlines

MarketRank^™

Overall MarketRank^™

0.50 out of 5 stars

Medical Sector

1579th out of 2,024 stocks

Management Consulting Services Industry

29th out of 46 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for DigiPath.

2.5 Community Rank

Outperform Votes
DigiPath has received 55 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
DigiPath has received 57 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
DigiPath has received 50.89% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about DigiPath and other stocks. Vote “Outperform” if you believe DIGP will outperform the S&P 500 over the long term. Vote “Underperform” if you believe DIGP will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
DigiPath does not currently pay a dividend.
Dividend Growth
DigiPath does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, DigiPath insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 10.80% of the stock of DigiPath is held by insiders.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of DigiPath is -1.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of DigiPath is -1.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
DigiPath has a P/B Ratio of 4.24. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

$0.04

0.00 (0.00 %)

(As of 04/16/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive DIGP News and Ratings via Email

Sign-up to receive the latest news and ratings for DIGP and its competitors with MarketBeat's FREE daily newsletter.

DigiPath (OTCMKTS:DIGP) Frequently Asked Questions

What stocks does MarketBeat like better than DigiPath?

Wall Street analysts have given DigiPath a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but DigiPath wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting DigiPath?

DigiPath saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 500 shares, a decline of 97.1% from the March 15th total of 17,400 shares. Based on an average trading volume of 94,300 shares, the short-interest ratio is currently 0.0 days.
View DigiPath's Short Interest.

When is DigiPath's next earnings date?

DigiPath is scheduled to release its next quarterly earnings announcement on Monday, May 17th 2021.
View our earnings forecast for DigiPath.

How were DigiPath's earnings last quarter?

DigiPath, Inc. (OTCMKTS:DIGP) posted its quarterly earnings results on Friday, February, 12th. The company reported ($0.01) EPS for the quarter. The company earned $0.50 million during the quarter. DigiPath had a negative trailing twelve-month return on equity of 1,137.19% and a negative net margin of 67.99%.
View DigiPath's earnings history.

How has DigiPath's stock price been impacted by Coronavirus (COVID-19)?

DigiPath's stock was trading at $0.0575 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, DIGP shares have decreased by 26.3% and is now trading at $0.0424.
View which stocks have been most impacted by COVID-19.

Who are DigiPath's key executives?

DigiPath's management team includes the following people:

Mr. Dennis Hartmann, Interim Pres & Director (Age 64, Pay $12k)
Mr. Todd A. Peterson CPA, CPA, CFO, Principal Accounting Officer, Treasurer & Sec. (Age 51, Pay $113.49k)
Mr. Philippe Henry, Chief Operating Officer
Dr. Drazen M. Jukic M.D., Ph.D., Exec. Officer
Mr. Bo Deitl, Consultant

Who are some of DigiPath's key competitors?

Some companies that are related to DigiPath include Canopy Growth (WEED), Innovative Industrial Properties (IIPR), GrowGeneration (GRWG), Leaf Mobile (LEAF), OrganiGram (OGI), 22nd Century Group (XXII), Emblem (EMC), ICC Labs (ICC), Bioventix (BVXP), KushCo (KSHB), NSAV (NSAV), Terra Tech (TRTC), General Cannabis (CANN), Pervasip (PVSP) and Grow Capital (GRWC).
View all of DIGP's competitors.

What other stocks do shareholders of DigiPath own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DigiPath investors own include Freedom Leaf (FRLF), AT&T (T), BP (BP), GrowGeneration (GRWG), KushCo (KSHB), Lumen Technologies (LUMN), AdvisorShares Pure US Cannabis ETF (MSOS), Rocky Mountain High Brands (RMHB), Terra Tech (TRTC) and Agritek (AGTK).

What is DigiPath's stock symbol?

DigiPath trades on the OTCMKTS under the ticker symbol "DIGP."

How do I buy shares of DigiPath?

Shares of DIGP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is DigiPath's stock price today?

One share of DIGP stock can currently be purchased for approximately $0.04.

How much money does DigiPath make?

DigiPath has a market capitalization of $2.89 million and generates $2.55 million in revenue each year.

How many employees does DigiPath have?

DigiPath employs 18 workers across the globe.

What is DigiPath's official website?

The official website for DigiPath is www.digipath.com.

Where are DigiPath's headquarters?

DigiPath is headquartered at 6450 CAMERON STREET SUITE 113, LAS VEGAS NV, 89118.

How can I contact DigiPath?

DigiPath's mailing address is 6450 CAMERON STREET SUITE 113, LAS VEGAS NV, 89118. The company can be reached via phone at 702-527-2060.

This page was last updated on 4/18/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here